Brief: Kala Bio Q4 EPS USD -1.74
31/03/2025 13:00
Mar 31 (Reuters) - Kala Bio Q4 net income USD -8.175 million. Q4 income from operations USD -9.459 million
Mar 31 (Reuters) - Kala Bio Q4 net income USD -8.175 million. Q4 income from operations USD -9.459 million